Filing Details

Accession Number:
0000905148-16-001816
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2016-08-09 17:25:20
Reporting Period:
2016-06-01
Filing Date:
2016-08-09
Accepted Time:
2016-08-09 17:25:20
Original Submission Date:
2016-06-01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1358762 Reata Pharmaceuticals Inc RETA Pharmaceutical Preparations (2834) 113651945
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1665299 Jr W James Traweek C/O Cpmg, Inc.
2000 Mckinney Ave., Suite 2125
Dallas TX 75201
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2016-06-01 802,000 $11.00 912,969 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
Footnotes
  1. These shares of Class A common stock ("Shares") were inadvertently omitted from the Reporting Person's Form 4 filed June 1, 2016, and subsequent Forms 4.
  2. These Shares were purchased in the Issuer's initial public offering, which closed on June 1, 2016.
  3. These Shares are held in various funds for which CPMG, Inc. serves as investment manager. The Reporting Person is a co-director and co-shareholder of CPMG, Inc.
  4. The Reporting Person disclaims beneficial ownership of the Shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.